Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
Relevant topics addressed-all dealt with in a systematic fashion-include adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, pregnancy complications, long-term metabolic and cardiovascular health, and finally cancer risk. Expand
Ultrasound assessment of the polycystic ovary: international consensus definitions.
Evidence for the current ultrasound definition of the polycystic ovary is outlined and a woman having PCO in the absence of an ovulation disorder or hyperandrogenism ('asymptomatic PCO') should not be considered as having PCOS, until more is known about this situation. Expand
The physiology and clinical utility of anti-Mullerian hormone in women.
- D. Dewailly, C. Andersen, +12 authors Richard A. Anderson
- Medicine, Biology
- Human reproduction update
- 1 May 2014
There is a linear relationship between AMH and oocyte yield after ovarian stimulation, which is of value in predicting ovarian hyperstimulation, and the submerged part of the iceberg of follicle growth, i.e. the intrinsic, so-called 'acyclic' ovarian activity is measured. Expand
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.
Describing data from the largest reported series of women with PCOS enables the development of a management-orientated approach to the syndrome. Expand
Non-invasive amino acid turnover predicts human embryo developmental capacity.
Non-invasive amino acid profiling has the potential to select developmentally competent single embryos for transfer, thereby increasing the success rate and eliminating multiple births in IVF. Expand
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
- T. Tang, J. Lord, R. Norman, E. Yasmin, A. Balen
- The Cochrane database of systematic reviews
There is no evidence that metformin improves live birth rates whether it is used alone or in combination with clomiphene, or when compared with clmiphene; therefore, the use of meetformin in improving reproductive outcomes in women with PCOS appears to be limited. Expand
Consensus on women's health aspects of polycystic ovary syndrome (PCOS).
Current knowledge is summarized and knowledge gaps regarding various women's health aspects of PCOS are identified, including adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, pregnancy complications, long-term metabolic and cardiovascular health and finally cancer risk. Expand
Polycystic ovaries and associated clinical and biochemical features in young women
To determine the prevalence of polycystic ovaries as identified by ultrasound in a group of young, postmenarcheal women in the normal population, and to investigate how polycystic ovaries are related… Expand
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
A possible ethnic difference in the clinical and biochemical characteristics of South Asian vs. Caucasian women with PCOS is determined. Expand
The adverse effects of obesity on conception and implantation.
The effect of obesity upon key reproductive mechanisms and its relation to fertility treatments is discussed and weight loss through lifestyle modification or bariatric surgery has been demonstrated to restore menstrual cyclicity and ovulation and improve the likelihood of conception. Expand